These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27081244)

  • 41. Treatment of vitiligo with 308-nm excimer laser: our experience from a 2-year follow-up of 979 Chinese patients.
    Fa Y; Lin Y; Chi XJ; Shi WH; Wang JL; Guo X; Geng JH; Liu HX; Zhang FR
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):337-340. PubMed ID: 27538097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
    Kumaran MS; Kaur I; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of Stable Vitiligo-A Review of the Surgical Approach.
    Grochocka M; Wełniak A; Białczyk A; Marek-Jozefowicz L; Tadrowski T; Czajkowski R
    J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902772
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
    Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
    Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The concept of stability of vitiligo: a reappraisal.
    Lahiri K; Malakar S
    Indian J Dermatol; 2012 Mar; 57(2):83-9. PubMed ID: 22615501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.
    Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM
    Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference.
    Gan EY; Eleftheriadou V; Esmat S; Hamzavi I; Passeron T; Böhm M; Anbar T; Goh BK; Lan CE; Lui H; Ramam M; Raboobee N; Katayama I; Suzuki T; Parsad D; Seth V; Lim HW; van Geel N; Mulekar S; Harris J; Wittal R; Benzekri L; Gauthier Y; Kumarasinghe P; Thng ST; Silva de Castro CC; Abdallah M; Vrijman C; Bekkenk M; Seneschal J; Pandya AG; Ezzedine K; Picardo M; Taïeb A;
    Pigment Cell Melanoma Res; 2017 Jan; 30(1):28-40. PubMed ID: 27864868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison between autologous noncultured extracted hair follicle outer root sheath cell suspension and autologous noncultured epidermal cell suspension in the treatment of stable vitiligo: a randomized study.
    Singh C; Parsad D; Kanwar AJ; Dogra S; Kumar R
    Br J Dermatol; 2013 Aug; 169(2):287-93. PubMed ID: 23517382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study.
    Nisticò S; Chiricozzi A; Saraceno R; Schipani C; Chimenti S
    Photomed Laser Surg; 2012 Jan; 30(1):26-30. PubMed ID: 22054204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acral lesions of vitiligo: why are they resistant to photochemotherapy?
    Esmat SM; El-Tawdy AM; Hafez GA; Zeid OA; Abdel Halim DM; Saleh MA; Leheta TM; Elmofty M
    J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1097-104. PubMed ID: 21851425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Micro - Focused Phototherapy Associated To Janus Kinase Inhibitor: A Promising Valid Therapeutic Option for Patients with Localized Vitiligo.
    Gianfaldoni S; Tchernev G; Wollina U; Roccia MG; Fioranelli M; Lotti J; Rovesti M; Satolli F; Valle Y; Goren A; Tirant M; Situm M; Kovacevic M; França K; Lotti T
    Open Access Maced J Med Sci; 2018 Jan; 6(1):46-48. PubMed ID: 29483979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.
    Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD
    J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and Safety of Targeted High-Intensity Medium-Band (304-312 nm) Ultraviolet B Light in Pediatric Vitiligo.
    Dong DK; Pan ZY; Zhang J; Lu XF; Jin C; Tao SQ; Yang LJ
    Pediatr Dermatol; 2017 May; 34(3):266-270. PubMed ID: 28318054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study.
    Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y
    Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repigmentation of vitiligo with autologous blister-induced epidermal grafts.
    Lim JT
    Ann Acad Med Singap; 1999 Nov; 28(6):824-8. PubMed ID: 10672396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study of clinical, biochemical and immunological factors determining stability of disease in patients with generalized vitiligo undergoing melanocyte transplantation.
    Rao A; Gupta S; Dinda AK; Sharma A; Sharma VK; Kumar G; Mitra DK; Prashant CK; Singh G
    Br J Dermatol; 2012 Jun; 166(6):1230-6. PubMed ID: 22329760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
    Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
    Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
    Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pimecrolimus cream in repigmentation of vitiligo.
    Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
    Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.